Phillip Taboada/X
Aug 26, 2025, 09:56
Phillip Taboada: TXA Shows No Added Benefit in Aquablation
Phillip Taboada, MS4 at UT Southwestern Medical Center and urology applicant, posted on X:
”New work in New work in Canadian J Urology.
Limited TUR during Aquablation provides adequate hemostasis. TXA offered no clear benefit in reducing hematuria or transfusions.
Thanks UT Southwestern Urology for the support!”
Read the full article here.
Title: Tranexamic acid and hematuria outcomes following aquablation for benign prostatic hyperplasia
Authors: Phillip Taboada, Rohit R. Badia, Dhillon Advano, Andrew Murphy, Christina Sze, Ryan J. Mauck, Jennifer Tse, Jeffrey Gahan, Claus G. Roehrborn, Ramy Goueli
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together